| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |